Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Insect anionic septapeptides suppress DENV replication by activating antiviral cytokines and miRNAs in primary human monocytes.

Limthongkul J, Mapratiep N, Apichirapokey S, Suksatu A, Midoeng P, Ubol S.

Antiviral Res. 2019 Aug;168:1-8. doi: 10.1016/j.antiviral.2019.04.012. Epub 2019 May 7.

PMID:
31075349
2.

In vitro antiviral activity of spirotetronate compounds against dengue virus serotype 2.

Euanorasetr J, Intra B, Thunmrongsiri N, Limthongkul J, Ubol S, Anuegoonpipat A, Kurosu T, Ikuta K, Nihira T, Panbangred W.

J Gen Appl Microbiol. 2019 Sep 14;65(4):197-203. doi: 10.2323/jgam.2018.10.001. Epub 2019 Feb 28.

3.

Heterogeneity of clinical isolates of chikungunya virus and its impact on the responses of primary human fibroblast-like synoviocytes.

Sukkaew A, Thanagith M, Thongsakulprasert T, Mutso M, Mahalingam S, Smith DR, Ubol S.

J Gen Virol. 2018 Apr;99(4):525-535. doi: 10.1099/jgv.0.001039. Epub 2018 Mar 8.

PMID:
29517478
4.

The synergistic effect of nsP2-L618, nsP3-R117, and E2-K187 on the large plaque phenotype of chikungunya virus.

Thoka B, Jaimipak T, Onnome S, Yoksan S, Ubol S, Pulmanausahakul R.

Virus Genes. 2018 Feb;54(1):48-56. doi: 10.1007/s11262-017-1524-1. Epub 2017 Nov 28.

PMID:
29185115
5.

Ubiquitin-Conjugating Enzyme E2 L3 is Downregulated by the Chikungunya Virus nsP2 Protease.

Ramphan S, Khongwichit S, Saisawang C, Kovanich D, Ketterman AJ, Ubol S, Auewarakul P, Roytrakul S, Smith DR, Kuadkitkan A.

Proteomics Clin Appl. 2018 Jul;12(4):e1700020. doi: 10.1002/prca.201700020. Epub 2017 Nov 16.

PMID:
28975709
6.

Small plaque size variant of chikungunya primary isolate showed reduced virulence in mice.

Jaimipak T, Yoksan S, Ubol S, Pulmanausahakul R.

Asian Pac J Allergy Immunol. 2018 Sep;36(3):201-205. doi: 10.12932/AP-250417-0079.

7.

EDIII-DENV3 nanospheres drive immature dendritic cells into a mature phenotype in an in vitro model.

Nantachit N, Sunintaboon P, Ubol S.

Microbiol Immunol. 2017 Aug;61(8):305-317. doi: 10.1111/1348-0421.12497.

8.

Glutathionylation of chikungunya nsP2 protein affects protease activity.

Saisawang C, Kuadkitkan A, Smith DR, Ubol S, Ketterman AJ.

Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):106-111. doi: 10.1016/j.bbagen.2016.10.024. Epub 2016 Oct 29.

PMID:
27984114
9.

Cell-type specific variation in the induction of ER stress and downstream events in chikungunya virus infection.

Khongwichit S, Wikan N, Abere B, Thepparit C, Kuadkitkan A, Ubol S, Smith DR.

Microb Pathog. 2016 Dec;101:104-118. doi: 10.1016/j.micpath.2016.11.009. Epub 2016 Nov 15.

PMID:
27863885
10.

A Field-Deployable Reverse Transcription Recombinase Polymerase Amplification Assay for Rapid Detection of the Chikungunya Virus.

Patel P, Abd El Wahed A, Faye O, Prüger P, Kaiser M, Thaloengsok S, Ubol S, Sakuntabhai A, Leparc-Goffart I, Hufert FT, Sall AA, Weidmann M, Niedrig M.

PLoS Negl Trop Dis. 2016 Sep 29;10(9):e0004953. doi: 10.1371/journal.pntd.0004953. eCollection 2016 Sep.

11.

Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination.

Nantachit N, Sunintaboon P, Ubol S.

Virol J. 2016 Aug 18;13:142. doi: 10.1186/s12985-016-0598-z.

12.

The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern.

Schaduangrat N, Phanich J, Rungrotmongkol T, Lerdsamran H, Puthavathana P, Ubol S.

J Gen Virol. 2016 Jun;97(6):1311-1323. doi: 10.1099/jgv.0.000444. Epub 2016 Mar 2.

13.

Chikungunya nsP2 protease is not a papain-like cysteine protease and the catalytic dyad cysteine is interchangeable with a proximal serine.

Saisawang C, Saitornuang S, Sillapee P, Ubol S, Smith DR, Ketterman AJ.

Sci Rep. 2015 Nov 24;5:17125. doi: 10.1038/srep17125.

14.

Immunogenic Properties of a BCG Adjuvanted Chitosan Nanoparticle-Based Dengue Vaccine in Human Dendritic Cells.

Hunsawong T, Sunintaboon P, Warit S, Thaisomboonsuk B, Jarman RG, Yoon IK, Ubol S, Fernandez S.

PLoS Negl Trop Dis. 2015 Sep 22;9(9):e0003958. doi: 10.1371/journal.pntd.0003958. eCollection 2015 Sep.

15.

Activity of andrographolide against chikungunya virus infection.

Wintachai P, Kaur P, Lee RC, Ramphan S, Kuadkitkan A, Wikan N, Ubol S, Roytrakul S, Chu JJ, Smith DR.

Sci Rep. 2015 Sep 18;5:14179. doi: 10.1038/srep14179.

16.

Full length and protease domain activity of chikungunya virus nsP2 differ from other alphavirus nsP2 proteases in recognition of small peptide substrates.

Saisawang C, Sillapee P, Sinsirimongkol K, Ubol S, Smith DR, Ketterman AJ.

Biosci Rep. 2015 Apr 22;35(3). pii: e00196. doi: 10.1042/BSR20150086.

17.

A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice.

Hunsawong T, Sunintaboon P, Warit S, Thaisomboonsuk B, Jarman RG, Yoon IK, Ubol S, Fernandez S.

Vaccine. 2015 Mar 30;33(14):1702-10. doi: 10.1016/j.vaccine.2015.02.016. Epub 2015 Feb 18.

18.

Differences in response of primary human myoblasts to infection with recent epidemic strains of Chikungunya virus isolated from patients with and without myalgia.

Lohachanakul J, Phuklia W, Thannagith M, Thongsakulprasert T, Smith DR, Ubol S.

J Med Virol. 2015 May;87(5):733-9. doi: 10.1002/jmv.24081. Epub 2015 Feb 5.

PMID:
25656089
19.

Assessment of flavaglines as potential chikungunya virus entry inhibitors.

Wintachai P, Thuaud F, Basmadjian C, Roytrakul S, Ubol S, Désaubry L, Smith DR.

Microbiol Immunol. 2015 Mar;59(3):129-41. doi: 10.1111/1348-0421.12230.

20.

Dengue virus infection of erythroid precursor cells is modulated by both thalassemia trait status and virus adaptation.

Sornjai W, Khungwanmaythawee K, Svasti S, Fucharoen S, Wintachai P, Yoksan S, Ubol S, Wikan N, Smith DR.

Virology. 2014 Dec;471-473:61-71. doi: 10.1016/j.virol.2014.10.004. Epub 2014 Oct 25.

21.

Involvement of ATP synthase β subunit in chikungunya virus entry into insect cells.

Fongsaran C, Jirakanwisal K, Kuadkitkan A, Wikan N, Wintachai P, Thepparit C, Ubol S, Phaonakrop N, Roytrakul S, Smith DR.

Arch Virol. 2014 Dec;159(12):3353-64. doi: 10.1007/s00705-014-2210-4. Epub 2014 Aug 29.

PMID:
25168043
22.

Comprehensive proteomic analysis of white blood cells from chikungunya fever patients of different severities.

Wikan N, Khongwichit S, Phuklia W, Ubol S, Thonsakulprasert T, Thannagith M, Tanramluk D, Paemanee A, Kittisenachai S, Roytrakul S, Smith DR.

J Transl Med. 2014 Apr 11;12:96. doi: 10.1186/1479-5876-12-96.

23.

Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/arthritis.

Phuklia W, Kasisith J, Modhiran N, Rodpai E, Thannagith M, Thongsakulprasert T, Smith DR, Ubol S.

Virus Res. 2013 Nov 6;177(2):179-88. doi: 10.1016/j.virusres.2013.08.011. Epub 2013 Sep 5.

PMID:
24012515
24.

Identification of prohibitin as a Chikungunya virus receptor protein.

Wintachai P, Wikan N, Kuadkitkan A, Jaimipuk T, Ubol S, Pulmanausahakul R, Auewarakul P, Kasinrerk W, Weng WY, Panyasrivanit M, Paemanee A, Kittisenachai S, Roytrakul S, Smith DR.

J Med Virol. 2012 Nov;84(11):1757-70. doi: 10.1002/jmv.23403.

PMID:
22997079
25.

Proteomic analysis of chikungunya virus infected microgial cells.

Abere B, Wikan N, Ubol S, Auewarakul P, Paemanee A, Kittisenachai S, Roytrakul S, Smith DR.

PLoS One. 2012;7(4):e34800. doi: 10.1371/journal.pone.0034800. Epub 2012 Apr 13.

26.

Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage.

Wikan N, Sakoonwatanyoo P, Ubol S, Yoksan S, Smith DR.

PLoS One. 2012;7(1):e31102. doi: 10.1371/journal.pone.0031102. Epub 2012 Jan 27.

27.

High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand.

Lohachanakul J, Phuklia W, Thannagith M, Thonsakulprasert T, Ubol S.

Microbiol Immunol. 2012 Feb;56(2):134-8. doi: 10.1111/j.1348-0421.2011.00417.x.

28.

Dengue virus type 2 recognizes the carbohydrate moiety of neutral glycosphingolipids in mammalian and mosquito cells.

Wichit S, Jittmittraphap A, Hidari KI, Thaisomboonsuk B, Petmitr S, Ubol S, Aoki C, Itonori S, Morita K, Suzuki T, Suzuki Y, Jampangern W.

Microbiol Immunol. 2011 Feb;55(2):135-40. doi: 10.1111/j.1348-0421.2010.00293.x.

29.

Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse.

Modhiran N, Kalayanarooj S, Ubol S.

PLoS Negl Trop Dis. 2010 Dec 21;4(12):e924. doi: 10.1371/journal.pntd.0000924.

30.

Intra-host diversities of the receptor-binding domain of stork faeces-derived avian H5N1 viruses and its significance as predicted by molecular dynamic simulation.

Ubol S, Suksatu A, Modhiran N, Sangma C, Thitithanyanont A, Fukuda M, Juthayothin T.

J Gen Virol. 2011 Feb;92(Pt 2):307-14. doi: 10.1099/vir.0.025973-0. Epub 2010 Oct 27.

31.

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes.

Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM.

Lancet Infect Dis. 2010 Oct;10(10):712-22. doi: 10.1016/S1473-3099(10)70166-3. Review.

32.

How innate immune mechanisms contribute to antibody-enhanced viral infections.

Ubol S, Halstead SB.

Clin Vaccine Immunol. 2010 Dec;17(12):1829-35. doi: 10.1128/CVI.00316-10. Epub 2010 Sep 28. Review.

33.

Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies.

Ubol S, Phuklia W, Kalayanarooj S, Modhiran N.

J Infect Dis. 2010 Mar 15;201(6):923-35. doi: 10.1086/651018.

PMID:
20158392
34.

Characteristics of stork feces-derived H5N1 viruses that are preferentially transmitted to primary human airway epithelial cells.

Suksatu A, Sangsawad W, Thitithanyanont A, Smittipat N, Fukuda MM, Ubol S.

Microbiol Immunol. 2009 Dec;53(12):675-84. doi: 10.1111/j.1348-0421.2009.00177.x.

35.

Characteristics of dengue virus-infected peripheral blood mononuclear cell death that correlates with the severity of illness.

Jaiyen Y, Masrinoul P, Kalayanarooj S, Pulmanausahakul R, Ubol S.

Microbiol Immunol. 2009 Aug;53(8):442-50. doi: 10.1111/j.1348-0421.2009.00148.x.

36.

Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells.

Ubol S, Chareonsirisuthigul T, Kasisith J, Klungthong C.

Virology. 2008 Jul 5;376(2):290-6. doi: 10.1016/j.virol.2008.03.030. Epub 2008 May 2.

37.

Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever.

Ubol S, Masrinoul P, Chaijaruwanich J, Kalayanarooj S, Charoensirisuthikul T, Kasisith J.

J Infect Dis. 2008 May 15;197(10):1459-67. doi: 10.1086/587699.

PMID:
18444802
38.

A novel cycloheptapeptide exerts strong anticancer activity via stimulation of multiple apoptotic pathways in caspase-3 deficient cancer cells.

Ubol S, Kramyu J, Masrinoul P, Kachangchaeng C, Pittayanurak P, Sophasan S, Reutrakul V.

Anticancer Res. 2007 Jul-Aug;27(4B):2473-9.

39.

Multiple enzyme activities of flavivirus proteins.

Padmanabhan R, Mueller N, Reichert E, Yon C, Teramoto T, Kono Y, Takhampunya R, Ubol S, Pattabiraman N, Falgout B, Ganesh VK, Murthy K.

Novartis Found Symp. 2006;277:74-84; discussion 84-6, 251-3. Review.

PMID:
17319155
40.

Attenuating characteristics of DEN-2 PDK53 in flavivirus-naïve peripheral blood mononuclear cells.

Rabablert J, Wasi C, Kinney R, Kasisith J, Pitidhammabhorn D, Ubol S.

Vaccine. 2007 May 10;25(19):3896-905. Epub 2007 Feb 5.

PMID:
17316931
42.

Screening of upregulated genes in suckling mouse central nervous system during the disease stage of rabies virus infection.

Ubol S, Kasisith J, Mitmoonpitak C, Pitidhamabhorn D.

Microbiol Immunol. 2006;50(12):951-9.

43.

Antiviral action of nitric oxide on dengue virus type 2 replication.

Takhampunya R, Padmanabhan R, Ubol S.

J Gen Virol. 2006 Oct;87(Pt 10):3003-11.

PMID:
16963759
44.

Inhibition of dengue virus replication by mycophenolic acid and ribavirin.

Takhampunya R, Ubol S, Houng HS, Cameron CE, Padmanabhan R.

J Gen Virol. 2006 Jul;87(Pt 7):1947-52.

PMID:
16760396
45.

Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-alpha on this pathway.

Pitidhammabhorn D, Kantachuvesiri S, Totemchokchyakarn K, Kitiyanant Y, Ubol S.

Clin Rheumatol. 2006 Sep;25(5):705-14. Epub 2006 Jan 4.

PMID:
16391890
46.

Genetic analysis of dog rabies viruses circulating in Bangkok.

Khawplod P, Shoji Y, Ubol S, Mitmoonpitak C, Wilde H, Nishizono A, Kurane I, Morimoto K.

Infect Genet Evol. 2006 May;6(3):235-40. Epub 2005 Aug 2.

PMID:
16061424
47.

Nitric oxide radical suppresses replication of wild-type dengue 2 viruses in vitro.

Charnsilpa W, Takhampunya R, Endy TP, Mammen MP Jr, Libraty DH, Ubol S.

J Med Virol. 2005 Sep;77(1):89-95.

PMID:
16032750
48.

Screening of pro-apoptotic genes upregulated in an experimental street rabies virus-infected neonatal mouse brain.

Ubol S, Kasisith J, Pitidhammabhorn D, Tepsumethanol V.

Microbiol Immunol. 2005;49(5):423-31.

49.

A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein.

Khawplod P, Inoue K, Shoji Y, Wilde H, Ubol S, Nishizono A, Kurane I, Morimoto K.

J Virol Methods. 2005 Apr;125(1):35-40. Epub 2005 Jan 11.

PMID:
15737414
50.

The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand.

Klungthong C, Zhang C, Mammen MP Jr, Ubol S, Holmes EC.

Virology. 2004 Nov 10;329(1):168-79.

Supplemental Content

Support Center